TY  - JOUR
T1  - Error in wording in: Persistence of cardiovascular risk after rofecoxib discontinuation
Y1  - 2011/02/28
N1  - 10.1001/archinternmed.2010.546
JO  - Archives of Internal Medicine
SP  - 305
EP  - 305
VL  - 171
IS  - 4
N2  - 
Error in Wording. In the Research Letter titled “Persistence of Cardiovascular Risk After Rofecoxib Discontinuation” by Ross et al, published in the December 13/27 issue of the Archives (2010;170[22]:2035-2036), an error occurred in the “Results” section on page 2035, where the last sentence should have read “Overall, an investigator-reported cardiovascular thromboembolic adverse event or death occurred during off-drug follow-up for 45 subjects, 32 in 287 patient-years among rofecoxib users and 13 in 234 patient-years among placebo users (RR, 2.01; 95% CI, 1.05-3.82; P = .03) (Figure).”

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2010.546
UR  - http://dx.doi.org/10.1001/archinternmed.2010.546
ER  -